American Century Companies Inc Arvinas, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 311,473 shares of ARVN stock, worth $5.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

311,473

Previous 325,590 4.34%

Holding current value

$5.67 Million

Previous $8.67 Million 11.49%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$23.66 - $32.73 $334,008 - $462,049	-14,117 Reduced 4.34%	311,473 $7.67 Million
Q2 2024 Aug 07, 2024	BUY	$24.46 - $40.4 $1,761 - $2,908	72 Added 0.02%	325,590 $8.67 Million
Q1 2024 May 14, 2024	SELL	$36.38 - $52.31 $2.54 Million - $3.65 Million	-69,849 Reduced 17.67%	325,518 $13.4 Million
Q4 2023 Feb 13, 2024	BUY	$14.19 - $42.33 $5.61 Million - $16.7 Million	395,367 New	395,367 $16.3 Million
Q3 2023 Nov 13, 2023	SELL	$19.64 - $28.21 $913,476 - $1.31 Million	-46,511 Reduced 5.41%	813,469 $16 Million
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $523,693 - $757,463	24,100 Added 2.88%	859,980 $21.3 Million
Q1 2023 May 11, 2023	SELL	$26.15 - $37.26 $2.34 Million - $3.34 Million	-89,538 Reduced 9.68%	835,880 $22.8 Million
Q4 2022 Feb 13, 2023	BUY	$32.47 - $57.24 $4.82 Million - $8.5 Million	148,560 Added 19.12%	925,418 $31.7 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $1.69 Million - $2.33 Million	40,259 Added 5.47%	776,858 $34.6 Million
Q2 2022 Aug 12, 2022	BUY	$36.01 - $74.24 $4.28 Million - $8.83 Million	118,993 Added 19.27%	736,599 $31 Million
Q1 2022 May 11, 2022	BUY	$60.27 - $81.57 $6.87 Million - $9.3 Million	114,020 Added 22.64%	617,606 $41.6 Million
Q4 2021 Feb 07, 2022	BUY	$65.85 - $96.21 $7.4 Million - $10.8 Million	112,408 Added 28.74%	503,586 $41.4 Million
Q3 2021 Nov 10, 2021	BUY	$73.2 - $107.87 $13,615 - $20,063	186 Added 0.05%	391,178 $32.1 Million
Q2 2021 Aug 05, 2021	BUY	$60.45 - $84.26 $897,924 - $1.25 Million	14,854 Added 3.95%	390,992 $30.1 Million
Q1 2021 May 14, 2021	SELL	$58.19 - $91.37 $4.46 Million - $7.01 Million	-76,727 Reduced 16.94%	376,138 $24.9 Million
Q4 2020 Feb 12, 2021	BUY	$20.19 - $84.93 $4.9 Million - $20.6 Million	242,790 Added 115.57%	452,865 $38.5 Million
Q3 2020 Nov 13, 2020	BUY	$22.99 - $36.34 $1.37 Million - $2.16 Million	59,441 Added 39.46%	210,075 $4.96 Million
Q2 2020 Aug 13, 2020	BUY	$29.88 - $56.74 $1.62 Million - $3.08 Million	54,359 Added 56.46%	150,634 $5.05 Million
Q1 2020 May 14, 2020	BUY	$33.0 - $54.5 $3.18 Million - $5.25 Million	96,275 New	96,275 $3.88 Million

Others Institutions Holding ARVN

# of Institutions

230

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $969M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Arvinas, Inc. Transaction History